19-35033964-C-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The ENST00000415950.5(SCN1B):​c.673C>T​(p.Arg225Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000663 in 1,552,498 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R225P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000066 ( 1 hom. )

Consequence

SCN1B
ENST00000415950.5 missense

Scores

3
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: -0.378

Publications

2 publications found
Variant links:
Genes affected
SCN1B (HGNC:10586): (sodium voltage-gated channel beta subunit 1) Voltage-gated sodium channels are heteromeric proteins that function in the generation and propagation of action potentials in muscle and neuronal cells. They are composed of one alpha and two beta subunits, where the alpha subunit provides channel activity and the beta-1 subunit modulates the kinetics of channel inactivation. This gene encodes a sodium channel beta-1 subunit. Mutations in this gene result in generalized epilepsy with febrile seizures plus, Brugada syndrome 5, and defects in cardiac conduction. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
HPN-AS1 (HGNC:47041): (HPN antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03603211).
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.0000657 (92/1400142) while in subpopulation MID AF = 0.000702 (4/5698). AF 95% confidence interval is 0.000239. There are 1 homozygotes in GnomAdExome4. There are 54 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN1BNM_001037.5 linkc.448+225C>T intron_variant Intron 3 of 5 ENST00000262631.11 NP_001028.1 Q07699-1
SCN1BNM_199037.5 linkc.673C>T p.Arg225Cys missense_variant Exon 3 of 3 NP_950238.1 Q07699-2
SCN1BNM_001321605.2 linkc.349+225C>T intron_variant Intron 3 of 5 NP_001308534.1 Q07699A0A1W2PR05

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN1BENST00000262631.11 linkc.448+225C>T intron_variant Intron 3 of 5 1 NM_001037.5 ENSP00000262631.3 Q07699-1

Frequencies

GnomAD3 genomes
AF:
0.0000723
AC:
11
AN:
152238
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000122
AC:
19
AN:
156104
AF XY:
0.000109
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000115
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000657
AC:
92
AN:
1400142
Hom.:
1
Cov.:
33
AF XY:
0.0000782
AC XY:
54
AN XY:
690716
show subpopulations
African (AFR)
AF:
0.000127
AC:
4
AN:
31608
American (AMR)
AF:
0.000168
AC:
6
AN:
35758
Ashkenazi Jewish (ASJ)
AF:
0.0000397
AC:
1
AN:
25186
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35750
South Asian (SAS)
AF:
0.000239
AC:
19
AN:
79522
European-Finnish (FIN)
AF:
0.0000203
AC:
1
AN:
49352
Middle Eastern (MID)
AF:
0.000702
AC:
4
AN:
5698
European-Non Finnish (NFE)
AF:
0.0000491
AC:
53
AN:
1079226
Other (OTH)
AF:
0.0000517
AC:
3
AN:
58042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000722
AC:
11
AN:
152356
Hom.:
0
Cov.:
32
AF XY:
0.0000537
AC XY:
4
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41576
American (AMR)
AF:
0.000131
AC:
2
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68034
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000154
Hom.:
0
Bravo
AF:
0.000117
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000227
AC:
1
ExAC
AF:
0.0000615
AC:
5
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 24, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: SCN1B c.673C>T (p.Arg225Cys) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00012 in 156104 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in SCN1B causing SCN1B-Related Disorders, allowing no conclusion about variant significance. c.673C>T has been reported in the literature in a case of sudden infant death syndrome (example: Neubauer_2018). These report(s) do not provide unequivocal conclusions about association of the variant with SCN1B-Related Disorders. At least one publication reports experimental evidence that this variant has a loss of function effect on sodium current, however, does not allow convincing conclusions about the variant effect (example: Neubauer_2018). The following publication has been ascertained in the context of this evaluation (PMID: 29915715). ClinVar contains an entry for this variant (Variation ID: 242250). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Brugada syndrome 5 Uncertain:1
Nov 25, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 225 of the SCN1B protein (p.Arg225Cys). This variant is present in population databases (rs369588692, gnomAD 0.02%). This missense change has been observed in individual(s) with sudden infant death syndrome (PMID: 28074886, 29915715). ClinVar contains an entry for this variant (Variation ID: 242250). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The cysteine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies have shown that this missense change affects SCN1B function (PMID: 29915715). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Uncertain:1
Apr 29, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported in a case of sudden infant death syndrome; no cardiac abnormalities were noted on autopsy (PMID: 29915715, 28074886); Electrophysiological studies suggest that p.(R225C) has a loss of function effect on sodium current; however, further studies are needed to confirm this finding (PMID: 29915715); In silico analysis indicates that this variant does not alter splicing; Reported using an alternate transcript of the gene; This variant is associated with the following publications: (PMID: 28074886, 29915715) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
0.59
DANN
Benign
0.52
Eigen
Benign
-1.9
Eigen_PC
Benign
-2.1
FATHMM_MKL
Benign
0.0083
N
LIST_S2
Benign
0.49
T;T
M_CAP
Uncertain
0.21
D
MetaRNN
Benign
0.036
T;T
MetaSVM
Benign
-0.74
T
PhyloP100
-0.38
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-0.48
N;.
REVEL
Benign
0.14
Sift
Uncertain
0.013
D;.
Sift4G
Uncertain
0.029
D;.
Polyphen
0.0
B;.
Vest4
0.093
MVP
0.20
MPC
0.91
ClinPred
0.079
T
GERP RS
-6.8
gMVP
0.19
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs369588692; hg19: chr19-35524868; API